Skip to main content
رجوع
ITGR logo

Integer Holdings Corporation

جودة البيانات: 100%
ITGR
NYSE Healthcare Medical - Devices
KWD 86.19
▲ KWD 0.86 (1.01%)
القيمة السوقية: 3.02B
نطاق اليوم
KWD 83.77 KWD 86.47
نطاق 52 أسبوعًا
KWD 62.00 KWD 127.56
حجم التداول
344,345
متوسط 50 يوم / 200 يوم
KWD 85.43 / KWD 94.09
الإغلاق السابق
KWD 85.33

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 29.4 0.3
P/B 1.7 2.9
ROE % 6.1 3.7
Net Margin % 5.6 3.8
Rev Growth 5Y % 11.0 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 102.750 +19.2%
Low: KWD 82.000 High: KWD 133.000
مكرر الربحية المستقبلي
13.2
ربحية السهم المستقبلية
KWD 6.491
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.8 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 8.640
KWD 8.504 – KWD 8.713
2.2 B 4
FY2028 KWD 7.882
KWD 7.758 – KWD 7.948
2.1 B 3
FY2027 KWD 7.225
KWD 7.023 – KWD 7.357
2 B 6

النقاط الرئيسية

Revenue grew 11.00% annually over 5 years — strong growth
Earnings declined -14.25% over the past year
Generating 105.12M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.02%
Cash machine — converts 102.24% of earnings into free cash flow
Capital efficient — spends only 4.91% of revenue on capex

النمو

Revenue Growth (5Y)
11.00%
Revenue (1Y)7.98%
Earnings (1Y)-14.25%
FCF Growth (3Y)32.06%

الجودة

Return on Equity
6.11%
ROIC5.71%
Net Margin5.55%
Op. Margin12.93%

الأمان

Debt / Equity
0.80
Current Ratio3.32
Interest Coverage5.55

التقييم

P/E Ratio
29.37
P/B Ratio1.73
EV/EBITDA18.37
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.98% Revenue Growth (3Y) 9.16%
Earnings Growth (1Y) -14.25% Earnings Growth (3Y) 6.50%
Revenue Growth (5Y) 11.00% Earnings Growth (5Y) 1.51%
Profitability
Revenue (TTM) 1.85B Net Income (TTM) 102.81M
ROE 6.11% ROA 3.01%
Gross Margin 26.99% Operating Margin 12.93%
Net Margin 5.55% Free Cash Flow (TTM) 105.12M
ROIC 5.71% FCF Growth (3Y) 32.06%
Safety
Debt / Equity 0.80 Current Ratio 3.32
Interest Coverage 5.55 Dividend Yield 0.00%
Valuation
P/E Ratio 29.37 P/B Ratio 1.73
P/S Ratio 1.63 PEG Ratio -1.49
EV/EBITDA 18.37 Dividend Yield 0.00%
Market Cap 3.02B Enterprise Value 4.40B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.85B 1.72B 1.56B 1.33B 1.22B
Net Income 102.81M 119.90M 90.65M 66.38M 96.81M
EPS (Diluted) 2.89 3.40 2.69 1.96 2.80
Gross Profit 500.39M 461.18M 411.52M 346.65M 336.97M
Operating Income 239.62M 208.24M 163.32M 112.68M 135.71M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.41B 3.08B 2.94B 2.79B 2.58B
Total Liabilities 1.66B 1.46B 1.42B 1.38B 1.23B
Shareholders' Equity 1.75B 1.62B 1.52B 1.42B 1.35B
Total Debt 1.40B 1.10B 1.05B 1.01B 905.81M
Cash & Equivalents 17.16M 46.54M 23.67M 24.27M 17.89M
Current Assets 770.10M 671.12M 617.67M 558.30M 452.98M
Current Liabilities 232.04M 227.17M 220.97M 223.75M 159.63M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#905 of 1052
26

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026